← Back to all trials
Active Not Recruiting
NCT07611500
Long-Term Risk of Kidney Stones in Living Kidney Donors
Conditions: Kidney Stones, Urolithiasis, Hypocitraturia, Living Kidney Donation, Living Kidney Donor
Sex: All
Ages: 18 Years – 105 Years
Healthy volunteers: Yes
Enrollment: 50000
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Summary
Using a population-based, matched, retrospective cohort approach, this study will evaluate the long-term risk of kidney stones among living kidney donors compared with matched healthy nondonors. Linked administrative health care databases from Ontario, Alberta, and British Columbia will be used and living kidney donors who donated between 1992 and 2024 will be identified and matched 1:10 to a carefully selected population of healthy nondonors based on baseline characteristics. The primary outcome is a surgical intervention for kidney stones (including shockwave lithotripsy, ureteroscopy or percutaneous nephrolithotomy). The secondary outcome is a hospital encounter with a kidney stone diagnosis.
Eligibility Criteria
\*Donors\*
Inclusion Criteria: Living kidney donors who underwent donor nephrectomy in Ontario, Alberta, and British Columbia, Canada, between July 1, 1992, and March 31, 2024 are eligible to enter the study.
Exclusion Criteria:
* Any person with data errors in their database records (such as missing or invalid age; it is expected to exclude very few persons for these reasons). Data errors also include evidence of prior dialysis or a prior solid organ transplant, as such individuals are not eligible to become donors.
* Any person who was not a permanent resident of the province (i.e., the patient lives outside of the province, and only came to the province to donate a kidney to the intended recipient). This will include anyone who is not eligible for the province's health insurance plan, anyone whose last contact date in the databases is less than 1 year after the cohort entry date, and anyone without a physician visit in the year following the nephrectomy hospital discharge.
* Any person who is \
Source: ClinicalTrials.gov (NCT07611500). StuddyBuddy aggregates publicly available trial information.